Dow And Teva: Indefiniteness Defense Can Be Powerful

In 2014, the U.S. Supreme Court in Nautilus Inc. v. Biosig Instruments Inc.[1] overturned the Federal Circuit's fundamental patent doctrine that a claim is definite when it is "amenable to construction"...

Already a subscriber? Click here to view full article